Theme: Profiling The Metabolome

Metabolomics Summit 2020

Metabolomics Summit 2020

Conference Series LLC Ltd welcomes you to attend the Annual Summit on Metabolomics which is  going to be held on  October 23-24, 2019, in Amsterdam, Netherlands. The relative innovative nature of the conference is to bring the Scientific Personnel among the sector of Metabolomics.

We warmly invite all the participants fascinated by sharing their information and analysis within the space of Metabolomics and its connected fields. Metabolomics Summit 2019 will lay a platform for creating a decent network with researchers and students from each domain and business from all continents, and aims to accelerate scientific discoveries and major milestones in Metabolomics Summit 2019 with a subject “Profiling The Metabolome”.

Metabolomics Summit 2019 are going to be underlined by the presence of academicians and industrialist participation together with Metabolomics Experts, Researcher, Industrial Giants, Business Representation  and Entrepreneurs etc. This meeting contains the Keynote Session, Speaker talks, Exhibition, Symposia, and Workshops.

Session 1 : Metabolic Biochemistry

Session 2 : Metabolomics and Metabolic Biomarkers

Session 3 : Cellular and Molecular Biology of Metabolomics

Session 4 : Microbiome and Metabolomics

Session 5 : Metabolic Diseases and Disorders

Session 6 : Metabolomics and Metabolic Diseases

Session 7 : Metabolomics in Cardiovascular Disease

Session 8 : Metabolomics in Cancer and Oncology

Session 9 : Metabolomics in Nervous System

Session 10 : Metabolomics in Ophthalmology

Session 11 : Metabolomic Technology and Bioinformatics

Session 12 : Analytical Platforms in Metabolomics

Session 13 : Clinical Metabolomics & Lipidomics

Session 14 : Metabolic Modelling and Synthetic Biology

Session 15 : Genomics and Proteomics in Medicine

Session 16 : New Application Areas of Metabolomics

Session 17 : Genomics Proteomics and Bioinformatics in Metabolomics

Session 18 : Metabolomics in Nutrition: Epidemiology, Health and Nutrition Research

Session 19 : Metabolomics and Child Health: Pregnancy, Neonatal Health, Childhood and Development

Session 20 : Gene Expression System and Metabolomics

Session 12 : Obesity and Metabolomics

Session 22 : Plant, Food, Environmental and Microbial Applications of Metabolomics

Session 23 : Metabolomics Market Watch


The Europe Metabolomics Market is worth USD 530 Million in 2018 and estimated to grow at a CAGR of 18.4%, to reach USD 1240 Million by 2023. The Europe Metabolomics market is emerging at an exceptionally quick speed.

Metabolomics is the considerable scale research of minute molecules, usually known as metabolites, inside cells, tissues or living beings. Aggregately, these tiny particles and their associations inside an organic framework are known as the metabolome. Therefore metabolomics characterizes to the microscopic phenotype. Metabolomics is a skilled approach since metabolites and their concentration not like other "omics" measures, directly reflect the hidden biochemical movement and state of cells.

Govt. financing and private funding are also reassuring the growth of this market. Metabolomics are in effect gradually sought after as they help in shrinking the hole between genotype and phenotype by offering a whole perspective of cell working. Stable innovative advances and looks into will guarantee a proceeded with development of this market and will decrease the effect of these restrictions in the future. Nonetheless, the unexplored markets in evolving countries will spur new progress open doors for market players.

Metabolomics Market are segmented by Product (GC, Bioinformatics, Mass Spectrometry, HPLC, UPLC, NMRS, surface based mass analysis,), Indication (Oncology, Cardiology, Inborn Errors), Application (Nutrigenomics, Toxicology, Biomarker & Drug Discovery), Biomarker Discovery segment had largest share in 2016 in the Europe metabolomics market. Efficiency and reliability has been cited as the reason for the growth of biomarkers. However collaboration between biotechnology and pharmaceutical companies, personalized medical segment is expected to have highest CAGR.

The Europe market has been geographically segmented into Germany, U.K, France, Spain, and Italy. The Europe had least CAGR during the forecast period.


To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 30-31, 2020
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View